Genesis Therapeutics

Senior Infrastructure Engineer - SRE & DevOps

Remote

Auto‑apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, AI for Drug DiscoveryIndustries

Requirements

Candidates should possess 5+ years of experience building and maintaining cloud infrastructure at scale, specifically within AWS or GCP, and demonstrate proficiency in Python, Bash, Terraform, and Kubernetes. Experience building and maintaining compute clusters running distributed ML training jobs with 1,000+ GPUs is highly desirable, along with hands-on experience with physical hardware and datacenter management.

Responsibilities

The Senior Infrastructure Engineer - SRE & DevOps will work on maintaining and growing the multi-cloud compute infrastructure supporting machine learning, computational chemistry, and drug discovery efforts, building out configuration and procedures for monitoring, resource allocation, and deployment automation. They will also contribute to orchestration scheduling frameworks to increase execution throughput, reliability, and compute utilization across heterogeneous pipelines, and advise management on HR-related risk mitigation strategies.

Skills

Python

Bash scripting

Terraform

Kubernetes

Cloud infrastructure

Distributed ML training

Multi-cloud management

Monitoring

Automation

Orchestration

Resource allocation

Autoscaling

Genesis Therapeutics

AI-driven drug discovery for pharmaceuticals

About Genesis Therapeutics

Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.

Key Metrics

Burlingame, CaliforniaHeadquarters

2019Year Founded

$272.5MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program

Risks

Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.

Over-reliance on partnerships could lead to financial instability if drugs aren't successful.

Rapid AI advancements may render current models like GEMS obsolete without updates.

Differentiation

Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.

The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.

Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Upsides

Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.

$224 million equity investment boosts research and development capabilities.

Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

Land your dream remote job 3x faster with AI

Try Jobo Free